These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 38758931)

  • 41. Application of hyperglycemia/diabetes-derived polygenic risk scores on the risk of poor outcomes after an ischemic stroke.
    Chen YL; Chi NF; Chiou HY; Hu CJ; Jeng JS; Tang SC; Lin HJ; Hsieh YC;
    J Chin Med Assoc; 2022 Jan; 85(1):81-87. PubMed ID: 35006127
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Polygenic risk scores for the prediction of common cancers in East Asians: A population-based prospective cohort study.
    Ho PJ; Tan IB; Chong DQ; Khor CC; Yuan JM; Koh WP; Dorajoo R; Li J
    Elife; 2023 Mar; 12():. PubMed ID: 36971353
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Polygenic Risk Score for Alzheimer's Disease in Caribbean Hispanics.
    Sariya S; Felsky D; Reyes-Dumeyer D; Lali R; Lantigua RA; Vardarajan B; Jiménez-Velázquez IZ; Haines JL; Shellenberg GD; Pericak-Vance MA; Paré G; Mayeux R; Tosto G
    Ann Neurol; 2021 Sep; 90(3):366-376. PubMed ID: 34038570
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Predictive Performance of a Polygenic Risk Score for Incident Ischemic Stroke in a Healthy Older Population.
    Neumann JT; Riaz M; Bakshi A; Polekhina G; Thao LTP; Nelson MR; Woods RL; Abraham G; Inouye M; Reid CM; Tonkin AM; Williamson JD; Donnan GA; Brodtmann A; Cloud GC; McNeil JJ; Lacaze P
    Stroke; 2021 Aug; 52(9):2882-2891. PubMed ID: 34039031
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Breast cancer risk prediction using a clinical risk model and polygenic risk score.
    Shieh Y; Hu D; Ma L; Huntsman S; Gard CC; Leung JW; Tice JA; Vachon CM; Cummings SR; Kerlikowske K; Ziv E
    Breast Cancer Res Treat; 2016 Oct; 159(3):513-25. PubMed ID: 27565998
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Polygenic and clinical risk scores and their impact on age at onset and prediction of cardiometabolic diseases and common cancers.
    Mars N; Koskela JT; Ripatti P; Kiiskinen TTJ; Havulinna AS; Lindbohm JV; Ahola-Olli A; Kurki M; Karjalainen J; Palta P; ; Neale BM; Daly M; Salomaa V; Palotie A; Widén E; Ripatti S
    Nat Med; 2020 Apr; 26(4):549-557. PubMed ID: 32273609
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Machine learning models for predicting blood pressure phenotypes by combining multiple polygenic risk scores.
    Hrytsenko Y; Shea B; Elgart M; Kurniansyah N; Lyons G; Morrison AC; Carson AP; Haring B; Mitchell BD; Psaty BM; Jaeger BC; Gu CC; Kooperberg C; Levy D; Lloyd-Jones D; Choi E; Brody JA; Smith JA; Rotter JI; Moll M; Fornage M; Simon N; Castaldi P; Casanova R; Chung RH; Kaplan R; Loos RJF; Kardia SLR; Rich SS; Redline S; Kelly T; O'Connor T; Zhao W; Kim W; Guo X; Ida Chen YD; ; Sofer T
    Sci Rep; 2024 May; 14(1):12436. PubMed ID: 38816422
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Schizophrenia polygenic risk scores, clinical variables and genetic pathways as predictors of phenotypic traits of bipolar I disorder.
    Grigoroiu-Serbanescu M; van der Veen T; Bigdeli T; Herms S; Diaconu CC; Neagu AI; Bass N; Thygesen J; Forstner AJ; Nöthen MM; McQuillin A
    J Affect Disord; 2024 Jul; 356():507-518. PubMed ID: 38640977
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genetic risk and gastric cancer: polygenic risk scores in population-based case-control study.
    Duan F; Liu L; Chen X; Yang Q; Wang Y; Zhang Y; Wang K
    Expert Rev Mol Diagn; 2023 Jun; 23(6):545-554. PubMed ID: 37086193
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Single Measurements of Carboxy-Terminal Fibroblast Growth Factor 23 and Clinical Risk Prediction of Adverse Outcomes in CKD.
    Edmonston D; Wojdyla D; Mehta R; Cai X; Lora C; Cohen D; Townsend RR; He J; Go AS; Kusek J; Weir MR; Isakova T; Pencina M; Wolf M;
    Am J Kidney Dis; 2019 Dec; 74(6):771-781. PubMed ID: 31445926
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cystatin C-based eGFR is a superior prognostic parameter to creatinine-based eGFR in post-endovascular therapy peripheral artery disease patients.
    Otaki Y; Takahashi H; Watanabe T; Yamaura G; Funayama A; Arimoto T; Shishido T; Miyamoto T; Kubota I
    Circ J; 2015; 79(11):2480-6. PubMed ID: 26354502
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Assessing Lung Cancer Absolute Risk Trajectory Based on a Polygenic Risk Model.
    Hung RJ; Warkentin MT; Brhane Y; Chatterjee N; Christiani DC; Landi MT; Caporaso NE; Liu G; Johansson M; Albanes D; Marchand LL; Tardon A; Rennert G; Bojesen SE; Chen C; Field JK; Kiemeney LA; Lazarus P; Zienolddiny S; Lam S; Andrew AS; Arnold SM; Aldrich MC; Bickeböller H; Risch A; Schabath MB; McKay JD; Brennan P; Amos CI
    Cancer Res; 2021 Mar; 81(6):1607-1615. PubMed ID: 33472890
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Can Predictive Modeling Tools Identify Patients at High Risk of Prolonged Opioid Use After ACL Reconstruction?
    Anderson AB; Grazal CF; Balazs GC; Potter BK; Dickens JF; Forsberg JA
    Clin Orthop Relat Res; 2020 Jul; 478(7):0-1618. PubMed ID: 32282466
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Stenting for peripheral artery disease of the lower extremities: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(18):1-88. PubMed ID: 23074395
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Modification of coronary artery disease clinical risk factors by coronary artery disease polygenic risk score.
    Truong B; Ruan Y; Haidermota S; Patel A; Surakka I; Hornsby W; Koyama S; Lee SH; Natarajan P
    Med; 2024 May; 5(5):459-468.e3. PubMed ID: 38642556
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The relation between apolipoprotein E (APOE) genotype and peripheral artery disease in patients at high risk for cardiovascular disease.
    Koopal C; Geerlings MI; Muller M; de Borst GJ; Algra A; van der Graaf Y; Visseren FL;
    Atherosclerosis; 2016 Mar; 246():187-92. PubMed ID: 26800308
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores.
    Bianco C; Jamialahmadi O; Pelusi S; Baselli G; Dongiovanni P; Zanoni I; Santoro L; Maier S; Liguori A; Meroni M; Borroni V; D'Ambrosio R; Spagnuolo R; Alisi A; Federico A; Bugianesi E; Petta S; Miele L; Vespasiani-Gentilucci U; Anstee QM; Stickel F; Hampe J; Fischer J; Berg T; Fracanzani AL; Soardo G; Reeves H; Prati D; Romeo S; Valenti L
    J Hepatol; 2021 Apr; 74(4):775-782. PubMed ID: 33248170
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognostic Value of a Polygenic Risk Score for Coronary Heart Disease in Individuals Aged 70 Years and Older.
    Neumann JT; Riaz M; Bakshi A; Polekhina G; Thao LTP; Nelson MR; Woods RL; Abraham G; Inouye M; Reid CM; Tonkin AM; McNeil J; Lacaze P
    Circ Genom Precis Med; 2022 Feb; 15(1):e003429. PubMed ID: 34949098
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Machine Learning Models of Polygenic Risk for Enhanced Prediction of Alzheimer Disease Endophenotypes.
    Gunter NB; Gebre RK; Graff-Radford J; Heckman MG; Jack CR; Lowe VJ; Knopman DS; Petersen RC; Ross OA; Vemuri P; Ramanan VK;
    Neurol Genet; 2024 Feb; 10(1):e200120. PubMed ID: 38250184
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Polygenic risk score improves the accuracy of a clinical risk score for coronary artery disease.
    King A; Wu L; Deng HW; Shen H; Wu C
    BMC Med; 2022 Nov; 20(1):385. PubMed ID: 36336692
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.